PRELUDE CAPITAL MANAGEMENT, LLC - SIO GENE THERAPIES INC ownership

SIO GENE THERAPIES INC's ticker is SIOX and the CUSIP is 829399104. A total of 55 filers reported holding SIO GENE THERAPIES INC in Q2 2021. The put-call ratio across all filers is 0.92 and the average weighting 0.1%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of SIO GENE THERAPIES INC
ValueSharesWeighting
Q3 2021$74,000
-20.4%
34,0000.0%0.00%
-33.3%
Q2 2021$93,000
+4.5%
34,0000.0%0.00%
+50.0%
Q1 2021$89,000
-6.3%
34,0000.0%0.00%0.0%
Q4 2020$95,00034,0000.00%
Other shareholders
SIO GENE THERAPIES INC shareholders Q2 2021
NameSharesValueWeighting ↓
Sassicaia Capital Advisers LLC 310,500$863,0001.79%
Consonance Capital Management LP 3,186,335$8,858,0000.83%
Opaleye Management Inc. 2,000,000$5,560,0000.73%
Sio Capital Management, LLC 886,665$2,465,0000.50%
Rubric Capital Management LP 2,335,200$6,492,0000.48%
Affinity Asset Advisors, LLC 250,000$695,0000.37%
GSA CAPITAL PARTNERS LLP 354,265$985,0000.16%
Hudson Bay Capital Management LP 3,200,000$8,896,0000.05%
Insight Advisors, LLC/ PA 24,000$67,0000.02%
Maven Securities LTD 86,788$246,0000.02%
View complete list of SIO GENE THERAPIES INC shareholders